Testing a new IV drug for serious fungal infections
Part of Infections clinical trials.
This trial tests BSG005, a new IV medicine for patients with invasive fungal infections that haven't improved with standard treatment or can't use standard treatments due to side effects or resistance. The goal is to see if it's safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a proven or probable invasive fungal infection (like from Aspergillus or Candida)
- Your current treatment either isn't working, caused kidney or electrolyte problems, or interacts badly with other meds
- Your kidney function is not severely reduced (eGFR at least 30) unless your creatinine is improving
- Your liver enzymes are not more than 5 times normal (or you can be retested in 48 hours)
- You are not pregnant, breastfeeding, or planning pregnancy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of antifungal medicines (liposomal amphotericin B and either isavuconazole or posaconazole) for people with blood cancers who develop a fungal infection despite taking preventive antifungal drugs. It aims to find a better treatment for these difficult infections.
This study tests a new antifungal drug (EL219) compared to two standard treatments (liposomal amphotericin B or voriconazole) for people with weakened immune systems who have a suspected or confirmed mold infection. The goal is to see if the new drug works as well or better at treating the infection.
This trial tests a new drug, Fosmanogepix, for treating serious mold infections that are hard to treat with current medicines. It may be an option for people with limited treatment choices.
This trial studies two types of antifungal medicines (amphotericin B and azoles) to see which works better for people with invasive fungal disease. It aims to help doctors choose the safest and most effective treatment.
This trial tests a new antifungal drug, HRS9432, for patients with candidemia (a yeast infection in the blood) or invasive candidiasis (yeast infection in organs). It aims to see if the drug is safe and works well for these serious infections.
This trial studies whether IV (through a vein) fosfomycin can treat severe bacterial infections in adults. It may help people whose infection is covered by the standard fosfomycin use and who need hospital-level care.
Hear when a new Invasive Fungal Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.